Showing results (771-780 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imagingL Aloj, M Panico, C Caraco, et al.Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 geneSuzanne M Verwijnen, Peter A E Sillevis Smith, Rob C Hoeben, et al.Cancer Biotherapy & Radiopharmaceuticals|August 24, 2005
Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes?Robert O Dillman, Linda Beutel, Shankar Nayak, et al.Cancer Biotherapy & Radiopharmaceuticals|August 24, 2005
MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptakeNathalie Perek, Nathalie Le Jeune, Delphine Denoyer, et al.Cancer Biotherapy & Radiopharmaceuticals|August 24, 2005
Metastatic renal carcinoma long-term survivors treated with s.c. interferon-alpha and s.c. interleukin-2Jens Atzpodien, Martina ReitzCancer Biotherapy & Radiopharmaceuticals|August 24, 2005
Activity of gelatins to induce secretion of a variety of cytokines from murine peritoneal exudate macrophagesTakashi Kojima, Yoshiaki Inamura, Tatsuro Koide, et al.Cancer Biotherapy & Radiopharmaceuticals|January 25, 2005
Safety, pharmacokinetics, immunogenicity, and biodistribution of (186)Re-labeled humanized monoclonal antibody BIWA 4 (Bivatuzumab) in patients with early-stage breast cancerManuel Koppe, Frank van Schaijk, Jan Roos, et al.Cancer Biotherapy & Radiopharmaceuticals|January 25, 2005
Continuous infusion interleukin-2 and antihistamines in melanoma: a retrospective review showing activity of this combinationMaria Evangelista-Dean, Nawazish Khan, Walter QuanCancer Biotherapy & Radiopharmaceuticals|January 25, 2005
High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanomaWalter Quan, Maria Ramirez, W Chris Taylor, et al.Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnosticsAnn-Charlott Steffen, Maria Wikman, Vladimir Tolmachev, et al.Pageof 223